Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer.
Zhou Y, D'Andrea VD, Shanmugam SP, Stelter I, Stormoen DR, Chroneos R, Hanlon T, Epstein I, Bekele RT, Anderson WJ, Carvalho FFL, Bellmunt J, Mouw KW.
Zhou Y, et al. Among authors: anderson wj.
Eur Urol. 2024 Mar 23:S0302-2838(24)02231-0. doi: 10.1016/j.eururo.2024.03.013. Online ahead of print.
Eur Urol. 2024.
PMID: 38523005
No abstract available.